XTL BIOPHARMACEUTICALS LTD. Reclassification Adjustments On Availableforsale Financial Assets Before Tax
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Reclassification Adjustments On Availableforsale Financial Assets Before Tax of $116.00 thousand for the 12-month period ending 2017-12-31, per its 20-F filed 2020-03-12.
Discontinued › Notes › Investments
ifrs-full:ReclassificationAdjustmentsOnAvailableforsaleFinancialAssetsBeforeTax · last filed 2020-03-12
| Period end | Reclassification Adjustments On Availableforsale Financial Assets Before Tax 12 month |
|---|---|
| 2017-12-31 | $116.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | -$163.00K 20-F · filed 2019-03-11 |